BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 12085181)

  • 1. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma.
    Oue N; Shigeishi H; Kuniyasu H; Yokozaki H; Kuraoka K; Ito R; Yasui W
    Int J Cancer; 2001 Sep; 93(6):805-9. PubMed ID: 11519041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
    Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents.
    Bearzatto A; Szadkowski M; Macpherson P; Jiricny J; Karran P
    Cancer Res; 2000 Jun; 60(12):3262-70. PubMed ID: 10866320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of cyclin D2 gene in gastric carcinoma.
    Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
    Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
    Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK; Mitra S
    Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
    Kim JI; Suh JT; Choi KU; Kang HJ; Shin DH; Lee IS; Moon TY; Kim WT
    Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
    Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
    Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.
    Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY
    Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
    Esteller M; Hamilton SR; Burger PC; Baylin SB; Herman JG
    Cancer Res; 1999 Feb; 59(4):793-7. PubMed ID: 10029064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
    Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
    Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
    Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
    Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
    Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
    Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K
    J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.